Nantahala Capital Management, LLC Acer Therapeutics Inc. Transaction History

Nantahala Capital Management, LLC

$1.5 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.57 - $1.28 $124,298 - $279,125	-218,067 Reduced 19.19%	918,349 $753,000
Q2 2023 Aug 14, 2023	SELL	$0.75 - $1.14 $50,032 - $76,049	-66,710 Reduced 5.54%	1,136,416 $1.05 Million
Q1 2023 May 15, 2023	SELL	$0.67 - $3.05 $15,453 - $70,348	-23,065 Reduced 1.88%	1,203,126 $914,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $4.15 $598,507 - $2.2 Million	529,653 Added 76.04%	1,226,191 $3.08 Million
Q3 2022 Nov 10, 2022	SELL	$1.28 - $1.6 $56,924 - $71,155	-44,472 Reduced 6.0%	696,538 $968,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $3.04 $43,803 - $111,902	-36,810 Reduced 4.73%	741,010 $934,000
Q1 2022 May 13, 2022	SELL	$1.98 - $2.98 $244,470 - $367,940	-123,470 Reduced 13.7%	777,820 $2.26 Million
Q4 2021 Feb 14, 2022	SELL	$1.88 - $2.9 $24,265 - $37,430	-12,907 Reduced 1.41%	901,290 $2.06 Million
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $47,283 - $58,795	-20,558 Reduced 2.2%	914,197 $2.34 Million
Q1 2021 May 14, 2021	SELL	$2.47 - $4.39 $135,850 - $241,449	-55,000 Reduced 5.56%	934,755 $2.91 Million
Q4 2020 Feb 16, 2021	SELL	$2.34 - $2.99 $2,106 - $2,691	-900 Reduced 0.09%	989,755 $2.59 Million
Q2 2019 Aug 14, 2019	BUY	$3.45 - $26.86 $366,390 - $2.85 Million	106,200 Added 12.01%	990,655 $3.86 Million
Q1 2019 May 15, 2019	SELL	$20.4 - $25.15 $387,600 - $477,850	-19,000 Reduced 2.1%	884,455 $21.5 Million
Q4 2018 Feb 14, 2019	BUY	$16.55 - $30.22 $3.51 Million - $6.41 Million	212,067 Added 30.67%	903,455 $18.2 Million
Q3 2018 Nov 14, 2018	BUY	$18.0 - $32.83 $7.94 Million - $14.5 Million	441,136 Added 176.28%	691,388 $21.3 Million
Q1 2018 May 15, 2018	BUY	$14.81 - $20.22 $3.71 Million - $5.06 Million	250,252 New	250,252 $4.82 Million

Others Institutions Holding ACER

# of Institutions

Shares Held

365

Call Options Held

Put Options Held

Burleson & Company, LLC

365
Shares

$0
0.0% of portfolio

View Full List

About Acer Therapeutics Inc.

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

More about ACER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account